Fig. 1From: Improved gut microbiota features after the resolution of SARS‑CoV‑2 infectionGut microbiota analysis of patients with or without severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection. A alpha diversity measures; B, C phyla and genera distribution; D linear discriminant analysis (LDA) effect size (LEfSe) highlighting differently abundant taxa between the study groupsBack to article page